That absence of evidence is not the same as evidence of no effect
This finding is important for product formulation: effective copper peptide products need precisely calibrated concentrations, not just "more copper peptide." Is this study considered reliable
However, there were no significant differences in HbA1c reductions between any of the cotadutide dose groups and the liraglutide (1.8 mg) group
However, the effect of persulfidation has almost not yet been explored
We believe patients living with this chronic disease who want and need treatment under the care of a licensed healthcare professional, including those embracing the growing telehealth community, deserve to get the real thing, said Moore
Limitations and Remaining Questions While semaglutide has shown significant benefits in reducing joint pain among patients with obesity, several important limitations remain: Studies often lack post-treatment follow-up, making it unclear how durable these pain and weight outcomes are once medication is stopped